Surgery Partners (SGRY) Shares Outstanding (Diluted Average) (2016 - 2025)
Surgery Partners (SGRY) has disclosed Shares Outstanding (Diluted Average) for 13 consecutive years, with $127.2 million as the latest value for Q4 2025.
- Quarterly Shares Outstanding (Diluted Average) rose 0.86% to $127.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $127.2 million through Dec 2025, up 0.86% year-over-year, with the annual reading at $127.2 million for FY2025, 0.86% up from the prior year.
- Shares Outstanding (Diluted Average) hit $127.2 million in Q4 2025 for Surgery Partners, roughly flat from $127.2 million in the prior quarter.
- In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $127.4 million in Q2 2023 to a low of $54.8 million in Q1 2021.
- Historically, Shares Outstanding (Diluted Average) has averaged $106.7 million across 5 years, with a median of $125.7 million in 2023.
- Biggest five-year swings in Shares Outstanding (Diluted Average): surged 64.81% in 2022 and later dropped 0.97% in 2024.
- Year by year, Shares Outstanding (Diluted Average) stood at $72.4 million in 2021, then rose by 26.96% to $92.0 million in 2022, then skyrocketed by 36.61% to $125.6 million in 2023, then grew by 0.41% to $126.1 million in 2024, then rose by 0.86% to $127.2 million in 2025.
- Business Quant data shows Shares Outstanding (Diluted Average) for SGRY at $127.2 million in Q4 2025, $127.2 million in Q3 2025, and $127.0 million in Q2 2025.